FDA Accepts Bristol Myers Squibb’s Priority Review for Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma Read more
ViroCell and AvenCell Partner on Retroviral Vector Manufacturing for Next-Gen CAR-T Blood Cancer Therapies Read more